Reliq Health Technologies Inc.

Reliq Health is a digital health company that provides innovative SaaS solutions to the $100 billion Virtual Care market. Reliq's proprietary iUGO Care platform supports Remote Patient Monitoring, Telemedicine, Chronic Care Management, Transitional Care Management and Behavioral Health Integration. The company has over 50 clients in the US, Australia and Canada. Reliq expects to achieve cash flow positive in Q1 2021 and profitability in Q2 2021, with gross margins over 75% and EBITDA margins over 45%.

Expert Comments:

Clive Maund, CliveMaund.com

"Reliq Health Technologies Inc. is rated an Immediate Buy here. It is down on support at the second low of what is believed to be [a] double bottom that formed following a quite heavy selloff."

read more >

Clive Maund, CliveMaund.com

"Developments led to a sharp breakout of Reliq Health Technologies Inc.'s stock late in July, which marked the start of the current vigorous uptrend. This move is probably targeting the CA$1.301.40 area. . .a likely scenario is that it stops to consolidate within the channel after last week's sharp gains before proceeding towards the target."

More Expert Comments

Experts Following This Company

Clive Maund – CliveMaund.com

Company News 

5/19/2022 – Reliq Health Technologies, Inc. Announces Go Live in Two Clinical Trials, New Contracts in TX and FL

5/11/2022 – Reliq Health Technologies, Inc. Announces 8 New Contracts to Onboard Patients in CA, MI, NV and TX, Adds MiUGO Patient Portal to iUGO Care RTM

4/27/2022 – Reliq Health Technologies, Inc. Announces New Contracts to Onboard over 8,000 New Patients

4/21/2022 – Reliq Health Technologies, Inc. Announces New Contracts in California, Nevada and Texas

4/18/2022 – Reliq Health Technologies, Inc. Responds to Short Seller Report

4/7/2022 – Reliq Health Technologies, Inc. Announces Six New Contracts in Texas, Nevada and Maryland; Collection of Aged Receivables

3/31/2022 – Reliq Health Technologies, Inc. to Present at the Lytham Partners Spring 2022 Investor Conference

3/24/2022 – Reliq Health Technologies, Inc. Announces New Contract, Expansion into Clinical Trials Market

3/16/2022 – Reliq Health Technologies, Inc. Announces Five New Contracts in the US, Expansion of Mental Health Care Capabilities

3/9/2022 – Reliq Health Technologies, Inc. Announces New Contracts with 6 Primary Care Clinics and a Maxillofacial Surgery Practice in Nevada

3/3/2022 – Reliq Health Technologies, Inc. Announces 5 New Contracts in Nevada, California and Texas

3/1/2022 – Reliq Health Technologies, Inc. Files Q2 FY2022 Quarterly Financial Statements, Provides Corporate Update

2/23/2022 – Reliq Health Technologies, Inc. to Present at Gravitas' 5th Annual Growth Conference

The information provided above is from analysts, newsletters, the company and other contributors.

Reliq Health Technologies Inc. is a former billboard advertiser of Streetwise Reports. The company's advertising fees paid for Streetwise Reports to create this "Investor Summary Page," to which links were placed on Streetwise Reports' websites and newsletters. Streetwise Reports did not accept stock for the payment of fees. See disclaimer for more details.

The company description, investing highlights and catalyst calendar on this page were prepared by the company. The Expert Comments and Experts Following This Company sections of this page are compiled by Streetwise Reports. There may be other information about the company that is not placed on this page. Streetwise Reports does not guarantee the accuracy or thoroughness of the information contained on this page.

The Expert Opinions above are excerpted from third-party sources not affiliated with or controlled by Streetwise Reports. The statements or opinions expressed in the Expert Opinions above are those of the authors indicated, and Streetwise Reports has not verified the accuracy of material excerpted here. Publications excerpted above may receive payment or sponsorship from the company mentioned.

Streetwise Reports does not provide investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security.Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.

Readers should conduct their own research for all information publicly available concerning the company.

Investing Highlights
Reliq has first mover advantage in the $100 Billion Community Care market
The Company expects to achieve profitability by the end of June 2021
Reliq expects consistent month over month revenue growth every month through 2021 and beyond
catalyst Calendar
New contracts expected every quarter
Cashflow positive by end of March, 2021
Profitability by end of June 2021